Vol 80, No 3 (2022)
Expert opinion
Published online: 2022-02-28

open access

Page views 5688
Article views/downloads 888
Get Citation

Connect on Social Media

Connect on Social Media

Management of patients after heart valve interventions. Expert opinion of the Working Group on Valvular Heart Diseases, Working Group on Cardiac Surgery, and Association of Cardiovascular Interventions of the Polish Cardiac Society

Edyta Płońska-Gościniak1, Wojciech Wojakowski2, Tomasz Kukulski3, Zbigniew Gąsior3, Marek Grygier4, Katarzyna Mizia-Stec5, Tomasz Hirnle6, Maria Olszowska78, Lidia Tomkiewicz-Pająk78, Jarosław D Kasprzak9, Piotr Suwalski10, Monika Komar78, Stanisław Bartuś11, Piotr Pysz2, Magdalena Mizia-Szubryt5, Tomasz T Hryniewiecki12
Pubmed: 35290659
Kardiol Pol 2022;80(3):386-402.

Abstract

Not available

References

  1. Otto C, Nishimura R, Bonow R, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021; 143(5): e35–e71.
  2. Gerber W, Sanetra K, Drzewiecka-Gerber A, et al. Long-term echocardiographic evaluation of asymptomatic patients undergoing minimally invasive valve repair for severe primary mitral regurgitation. Kardiol Pol. 2020; 78(6): 545–551.
  3. El Gabry M, Mourad F, Loosen L, et al. A new simplified technique for artificial chordae implantation in mitral valve repair with its early results. J Thorac Dis. 2020; 12(3): 724–732.
  4. Kaneyuki D, Nakajima H, Asakura T, et al. Midterm results of mitral valve repair for atrial functional mitral regurgitation: a retrospective study. J Cardiothor Surgery. 2020; 312(15): 1–7.
  5. Tamborini G, Mantegazza V, Penso M, et al. Predictive Value of Pre-Operative 2D and 3D Transthoracic Echocardiography in Patients Undergoing Mitral Valve Repair: Long Term Follow Up of Mitral Valve Regurgitation Recurrence and Heart Chamber Remodeling. J Cardiovasc Dev Dis. 2020; 7(4).
  6. Lavall D, Bruns J, Stegmann T, et al. Long-term clinical and haemodynamic results after transcatheter annuloplasty for secondary mitral regurgitation. ESC Heart Fail. 2021; 8(4): 2448–2457.
  7. Kitamura H, Kagase Ai, Koyama Y, et al. Early and long-term results of surgery for secondary mitral regurgitation with a damaged heart. J Card Surg. 2019; 34(10): 919–926.
  8. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
  9. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases [article in Polish]. Kardiol Pol. 2014; 72(12): 1169–1252.
  10. de Heer F, Kluin J, Elkhoury G, et al. AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. J Thorac Cardiovasc Surg. 2019; 157(6): 2202–2211.
  11. Berrebi A, Monin JL, Lansac E. Systematic echocardiographic assessment of aortic regurgitation-what should the surgeon know for aortic valve repair? Ann Cardiothorac Surg. 2019; 8(3): 331–341.
  12. Zoghbi W, Chambers J, Dumesnil J, et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr. 2009; 22(9): 975–1014.
  13. Lancellotti P, Pibarot P, Chambers J, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17(6): 589–590.
  14. Okamura H, Hori D, Kusadokoro S, et al. Long-Term outcomes and echocardiographic data after aortic valve replacement with a 17-mm mechanical valve. Circ J. 2020; 84(12): 2312–2319.
  15. Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the european association of cardiovascular imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017; 30(2): 101–138.
  16. van Osch D, Dieleman JM, Bunge JJ, et al. Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery. J Thorac Cardiovasc Surg. 2017; 153(4): 878–885.e1.
  17. Berdajs D, Schurr UP, Wagner A, et al. Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty. Eur J Cardiothorac Surg. 2008; 34(1): 55–61.
  18. Hwang YMi, Kim J, Lee JiH, et al. Conduction disturbance after isolated surgical aortic valve replacement in degenerative aortic stenosis. J Thorac Cardiovasc Surg. 2017; 154(5): 1556–1565.e1.
  19. Bisson A, Bodin A, Herbert J, et al. Pacemaker implantation after balloon- or self-expandable transcatheter aortic valve replacement in patients with aortic stenosis. J Am Heart Assoc. 2020; 9(9): e015896.
  20. Wang TK, Griffin BP, Miyasaka R, et al. Isolated surgical tricuspid repair versus replacement: meta-analysis of 15 069 patients. Open Heart. 2020; 7(1): e001227.
  21. Mar PL, Angus CR, Kabra R, et al. Perioperative predictors of permanent pacing and long-term dependence following tricuspid valve surgery: a multicentre analysis. Europace. 2017; 19(12): 1988–1993.
  22. Bilkhu R, Jahangiri M, Otto CM. Patient-prosthesis mismatch following aortic valve replacement. Heart. 2019; 105(Suppl 2): s28–s33.
  23. Hwang HoY, Kim YH, Kim KH, et al. Patient-Prosthesis mismatch after mitral valve replacement: a propensity score analysis. Ann Thorac Surg. 2016; 101(5): 1796–1802.
  24. Hirnle T, Borzymowski J, Mitrosz M, et al. Management of paravalvular leak [article in Polish]. Kardiologia po Dyplomie. 2018; 4(17): 1–9.
  25. Thiele H, Kurz T, Feistritzer HJ, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020; 41(20): 1890–1899.
  26. Surgical Treatment of Aortic Valve Disease. In: Sellke FW, del Nido PJ, Swanson SJ. Sabiston & Spencer Suregry of the Chest. 9 th ed. Elsevier 2016: 1335–1349.
  27. Furukawa H, Tanemoto K. Redo valve surgery — current status and future perspectives. Ann Thorac Cardiovasc Surg. 2014; 20(4): 267–275.
  28. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009; 137(1): 82–90.
  29. Furukawa H, Tanemoto K. Current status and future perspectives of prosthetic valve selection for aortic valve replacement. Gen Thorac Cardiovasc Surg. 2014; 62(1): 19–23.
  30. LaPar DJ, Yang Z, Stukenborg GJ, et al. Outcomes of reoperative aortic valve replacement after previous sternotomy. J Thorac Cardiovasc Surg. 2010; 139(2): 263–272.
  31. Amano J, Kuwano H, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2011: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2013; 61(10): 578–607.
  32. Parma R, Zembala MO, Dąbrowski M, et al. Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society…. Kardiol Pol. 2017; 75(9): 937–964.
  33. Wojakowski W, Chmielak Z, Widenka K, et al. Transcatheter mitral valve repair and replacement. Expert consensus statement of the Polish Cardiac Society and the Polish Society of Cardiothoracic Surgeons. Kardiol Pol. 2021; 79(10): 1165–1177.
  34. Rdzanek A, Szymański P, Gackowski A, et al. Percutaneous tricuspid edge-to-edge repair — patient selection, imaging considerations, and the procedural technique. Expert opinion of the Working Group on Echocardiography and Association of CardioVascular Interventions of the Polish Cardiac Society. Kardiol Pol. 2021; 79(10): 1178–1191.
  35. Carroll JD, Mack MJ, Vemulapalli S, et al. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol. 2013; 62(11): 1026–1034.
  36. Alperi A, Garcia S, Rodés-Cabau J. Transcatheter valve-in-valve implantation in degenerated surgical aortic and mitral bioprosthesis: Current state and future perspectives. Prog Cardiovasc Dis. 2021 [Epub ahead of print].
  37. Bhargava AA, Shekiladze N, Xie J, et al. Use of transesophageal echocardiography for transcatheter valve-in-valve implantation for patients with prior bioprosthetic surgical aortic, mitral, tricuspid, and pulmonic valves. Ann Cardiothorac Surg. 2021; 10(5): 605–620.
  38. Huczek Z, Jędrzejczyk S, Jagielak D, et al. Transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses: results from Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV-TAVI) Registry. Pol Arch Intern Med. 2021 [Epub ahead of print].
  39. Nouthe B, Noubiap JJ, Effoe VS. Meta-Analysis: Valve-in-Valve TAVR Versus Redo SAVR. JACC Cardiovasc Interv. 2021; 14(10): 1157.
  40. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021; 77(4): e25–e2e197.
  41. Ruiz CE, Hahn RT, Berrebi A, et al. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. J Am Coll Cardiol. 2017; 69(16): 2067–2087.
  42. Zoghbi W, Chambers J, Dumesnil J, et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr. 2009; 22(9): 975–1014.
  43. Pibarot P, Hahn RT, Weissman NJ, et al. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. JACC Cardiovasc Imaging. 2015; 8(3): 340–360.
  44. Zoghbi WA, Asch FM, Bruce C, et al. Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2019; 32(4): 431–475.
  45. Pysz P, Kozłowski M, Malczewska M, et al. Prospective registry validating the reproducibility of mitral paravalvular leak measurements in a standardized real-time three-dimensional transesophageal echocardiography algorithm for optimal choice of the closure device. Postepy Kardiol Interwencyjnej. 2019; 15(2): 203–210.
  46. Sun JCJ, Davidson MJ, Lamy A, et al. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet. 2009; 374(9689): 565–576.
  47. Stone GW, Lindenfeld JA, Abraham WT, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018; 379(24): 2307–2318.
  48. Ailawadi G, Lim DS, Grayburn PA, et al. One-Year outcomes after MitraClip for functional mitral regurgitation. Circulation. 2019; 139(1): 37–47.
  49. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy [article in Polish]. Kardiol Pol. 2019; 77(3): 245–326.
  50. Yurdakök M. Fetal and neonatal effects of anticoagulants used in pregnancy: a review. Turk J Pediatr. 2012; 54(3): 207–215.
  51. Scheres LJJ, Bistervels IM, Middeldorp S. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy. Blood Rev. 2019; 33: 82–97.
  52. Alshawabkeh L, Economy KE, Valente AM. Anticoagulation during pregnancy: evolving strategies with a focus on mechanical valves. J Am Coll Cardiol. 2016; 68(16): 1804–1813.
  53. Trzeciak P, Zembala M, Foremny J. They implanted, discharged and ... forgot – an old fairy tale or an up-to-date story about caring for a patient after an artificial heart valve implantation? [article in Polish]. Kardiol Pol. 2008; 66(5): 601–605.
  54. Laplace G, Lafitte S, Labèque JN, et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J Am Coll Cardiol. 2004; 43(7): 1283–1290.
  55. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management [article in Polish]. Kardiol. Pol. 2014; 72(10): 857–918.
  56. Devereaux PJ, Goldman L, Cook DJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005; 173(6): 627–634.
  57. Smilowitz NR, Berger JS. Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review. JAMA. 2020; 324(3): 279–290.
  58. Grasshoff C, Magunia H. Cardiovascular risk assessment for noncardiac surgery. JAMA. 2020; 324(20): 2105–2106.
  59. Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015; 373(9): 823–833.
  60. Kristensen SD, Knuuti J, Saraste A, et al. Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35(35): 2383–2431.